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Summary
 
Adhesion receptors that are known to initiate contact (tethering) between blood-borne leuko-
cytes and their endothelial counterreceptors are frequently concentrated on the microvilli of
leukocytes. Other adhesion molecules are displayed either randomly or preferentially on the
planar cell body. To determine whether ultrastructural distribution plays a role during tethering
in vivo, we used pre-B cell transfectants expressing L- or E-selectin ectodomains linked to
transmembrane/intracellular domains that mediated different surface distribution patterns. We
analyzed the frequency and velocity of transfectant rolling in high endothelial venules of pe-
ripheral lymph nodes using an intravital microscopy model. Ectodomains on microvilli con-
ferred a higher efficiency at initiating rolling than random distribution which, in turn, was
more efficient than preferential expression on the cell body. The role of microvillous presenta-
tion was less accentuated in venules below 20 
 
m
 
m in diameter than in larger venules. In the
narrow venules, tethering of cells with cell body expression may have been aided by forced
margination through collision with erythrocytes. L-selectin transfected cells rolled 10-fold
faster than E-selectin transfectants. Interestingly, rolling velocity histograms of cell lines ex-
pressing equivalent copy numbers of the same ectodomain were always similar, irrespective of
the topographic distribution. Our data indicate that the distribution of adhesion receptors has a
dramatic impact on contact initiation between leukocytes and endothelial cells, but does not
play a role once rolling has been established.
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D
 
ifferential expression of a variety of leukocyte adhesion
molecules, endothelial counterreceptors, and activating
signals constitutes the basis of tissue-specific adhesion (hom-
ing) of leukocyte subsets during immune surveillance and
inflammation. Thus far, only the selectin family (E-, P-, and
L-selectin) and the 
 
a
 
4 integrins have been shown to mediate
initial contact (tethering) between free-flowing leukocytes
and endothelium in vivo. Subsequently, these receptors en-
able the tethered leukocytes to roll along the vessel wall (1,
2). Rolling leukocytes may adhere firmly by activation-
induced interactions of leukocyte integrins with endothelial
counterreceptors and transmigrate through the endothelium
into the surrounding tissue (1, 2).
The adhesion cascade that mediates homing of lympho-
cytes to peripheral lymph nodes (PLN)
 
1
 
 has been elucidated
recently on a single cell level (3). Lymphocytes enter special-
ized subcortical postcapillary venules, called high endothelial
venules (HEV), where they tether and roll via L-selectin
binding to its endothelial counterreceptor, the peripheral
node addressin (PNAd) (3–5), a mixture of sulfated mucin-
like sialoglycoproteins defined by the mAb MECA-79 (6,
7). A subset of rolling lymphocytes attaches firmly after ac-
 
1
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tivation of LFA-1 via a G protein–coupled activation path-
way (3) and then transmigrates into the lymph node.
Experiments using neutralizing mAbs or mice that are
genetically deficient in L-selectin indicate that L-selectin–
dependent tethering and rolling is essential for lymphocyte
homing to PLN (8, 9). In vitro studies suggest that this cru-
cial function of L-selectin may be enhanced by its conspic-
uous surface presentation; L-selectin is preferentially ex-
pressed on the tips of microvilli on leukocytes (10, 11),
structures long hypothesized to mediate mutual engage-
ment with endothelium (12). Similar to L-selectin, other
adhesion molecules capable of mediating tethering such as
P-selectin glycoprotein ligand-1 (PSGL-1) and the 
 
a
 
4 inte-
grins (primary adhesion receptors) are also targeted to mi-
crovilli (13–15). Consequently, the predominance of L-selec-
tin and other primary adhesion receptors on the most distal
part of the leukocytes was postulated to facilitate contact
with the vessel wall (10–15).
To address this hypothesis, experiments involving do-
main exchanges between the ectodomain (ED) and the
transmembrane and intracellular (TM/IC) domains of L-selec-
tin and CD44 (which is predominantly expressed on the
cell body, i.e., excluded from microvilli) have revealed that
the TM/IC domains of these proteins determine the spatial
distribution of the ED when expressed in the murine pre-B
cell line L1-2 (16). In flow chamber assays, L-selectin EDs
targeted away from microvilli on the surface of these trans-
fectants were less efficient in initiating tethering to PNAd
and mAbs against L-selectin than L-selectin on the tips of
microvilli (16).
However, adhesion conditions in vivo differ in several
points from those in flow chamber assays. For example, due
to the microvascular anatomy, leukocytes are already in
close proximity to endothelial cells (EC) upon entry into
postcapillary venules and they experience frequent colli-
sions with erythrocytes (17). These physiologic features are
thought to promote efficient margination and might render
microvillous presentation irrelevant. On the other hand, in
vitro studies have shown that microvillous presentation
may be increasingly advantageous for tethering when shear
rates are increased (16). Leukocytes must tether to EC in
vivo in the presence of much higher shear stresses than
those employed in vitro (18). Furthermore, electrostatic re-
pulsion between negatively charged glycocalices on the
surface of leukocytes (19, 20) and EC (21) may increase the
need for exposing adhesion molecules capable of initiating
contact on microvilli.
Here, we have taken advantage of the constitutive
PNAd expression in PLN to investigate the influence of
adhesion receptor distribution in a recently developed in-
travital microscopy model (5). Our findings confirm that
microvillous expression of L-selectin EDs is indeed impor-
tant for the ability of cells to tether on PLN venules in
vivo, and differentiate the role of receptor topography in
leukocyte tethering to venules of different diameter. To
confirm the importance of adhesion receptor presentation
for a pathway not involving L-selectin, we also analyzed
the in vivo behavior of L1-2 transfectants expressing wild-
 
type and chimeric E-selectin with different surface distribu-
tion, based on the observation that E-selectin can bind to
PNAd in vitro (22, 23). Finally, our findings suggest that
the distribution of EDs has no influence on the behavior of
cells once rolling has been established.
 
Materials and Methods
 
Antibodies and Reagents.
 
Anti–human L-selectin mAb DREG-
200 (murine IgG1) (24) was purified from hybridoma culture su-
pernatants following standard procedures. Anti–human E-selectin
mAb CL-3 (murine IgG1) (25) was generously provided by Dr.
C. Wayne Smith (Baylor College of Medicine, Houston, TX).
Polyphosphomannan ester (PPME)-FITC was kindly provided
by Dr. Lloyd Stoolman (University of Michigan, Ann Arbor,
MI). FITC-dextran (150 kD) was purchased from Sigma Chemi-
cal Co. Before injection into animals, FITC-dextran was dis-
solved to 10 mg/ml in sterile saline and centrifuged to remove
nonsoluble particles. 2
 
9
 
,7
 
9
 
,-bis-(2-carboxyethyl)-5(and-6) carboxy-
fluorescein (BCECF; Molecular Probes) was dissolved in DMSO
to 0.5 mg/ml and used within 1 wk.
 
Cell Lines.
 
Murine L1-2 pre-B lymphoma cell lines stably
transfected with human wild-type E- and L-selectin have been
reported previously (4, 5, 11, 16, 26). The following chimeric
L1-2 transfectants, generated by fusing the ED of L- or E-selec-
tin to the TM/IC domain of other surface receptors, have also
been described previously (16): L-selectin ED/CD44 TM/IC
(L/CD44), and E-selectin ED/L-selectin TM/IC (E/L). L-selec-
tin ED/CD31 TM/IC (L/CD31) was generated in an analogous
fashion. In brief, cDNA fragments of the human L-selectin ED and
the human CD31 TM/IC domain (a full-length clone was kindly
provided by Dr. J. Zehnder, Stanford University, Stanford, CA)
(27) were generated by PCR using primers with appropriate
overhangs. L/CD31 chimeric cDNA was generated in a second
PCR reaction by sequence overlap extension (28). The construct
was subcloned in pMRB101 and stably expressed in L1-2 cells
following standard procedures. The determination of the surface
distribution of the transfected molecules was carried out using
low voltage scanning immunoelectron microscopy as described
(16). The fusion sites and the surface distribution of the trans-
fected constructs on L1-2 cells are shown in Fig. 1. A parental
cell line transfected with the pMRB101 expression vector alone
(L1-2
 
Vector
 
) was used as a negative control. L1-2 transfectants
were grown in six-well plates in RPMI 1640 containing 10%
FCS, standard supplements, 250 
 
m
 
g/ml mycophenolic acid
(Sigma Chemical Co.), 12.5 
 
m
 
g/ml xanthine (Sigma Chemical
Co.), and 1
 
3
 
 hypoxanthine/thymidine (GIBCO BRL).
On the day of an experiment, cells were harvested and
counted on a hemocytometer. If 
 
.
 
10% dead cells (as determined
by Trypan blue exclusion) were present, viable cells were en-
riched by centrifugation over a Ficoll gradient. Thus, the viability
of all cells used in this study was at least 90%. Subsequently, cells
were resuspended to 10
 
7
 
 cells/ml in prewarmed (37
 
8
 
C) RPMI
1640 containing 10% FCS and standard supplements. For fluores-
cent labeling, cells were incubated for 30 min at 37
 
8
 
C after add-
ing 2.5 
 
m
 
g BCECF/10
 
7
 
 cells. Labeled cells were washed twice
before resuspending them to a final concentration of 1 or 1.5 
 
3
 
10
 
7
 
 cells/ml. Aliquots of cells were treated identically, except that
no BCECF was added. These samples were then transferred to
ice-cold media and stained with mAbs for flow cytometric assess-
ment of receptor expression (see below).
 
FACS
 
®
 
 Analysis.
 
Expression levels of wild-type and chi-
meric selectins were assessed before and after each experiment. 
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Transfectants were resuspended in cold PBS containing 1% BSA
and 10 
 
m
 
g/ml mAb DREG-200 or mAb CL-3 and incubated for
20 min at 4
 
8
 
C. After washing twice, cells were incubated with
PE- or FITC-conjugated goat anti–mouse Ig (Biosource Interna-
tional) for 20 min at 4
 
8
 
C. Cells were washed twice and then ana-
lyzed on a FACScan
 
®
 
 flow cytometer (Becton Dickinson). L1-
2
 
Vector
 
 transfectants were stained identically and served as negative
control. The mean copy number of wild-type and chimeric
ectodomains on transfected cells was estimated using a calibrated
microbead system (Quantum Simply Cellular; Flow Cytometry
Standards Corp.) following the manufacturer’s instructions.
Although all L1-2 transfectants were stably transfected sub-
clones, expression levels varied considerably during culture.
Therefore, to allow comparison of cells expressing different re-
ceptor topographies, but similar levels of EDs, each transfected
cell line was sorted and subcloned. Different subclones were cho-
sen for in vivo experiments when their mean absolute expression
levels of selectin EDs were within 
 
6
 
30% of each other and when
the nonexpressing population was 
 
,
 
10%.
 
PPME-FITC Binding Assay.
 
PPME-FITC binding assays were
carried out as described previously (29). In brief, 10
 
6
 
 cells were
resuspended in 0.2 ml DMEM containing 40 mM Hepes and
10% FBS (assay media) and kept on ice for 30 min in the pres-
ence of assay media with or without 25 mM EDTA or 25 
 
m
 
g/ml
mAb DREG-200. Subsequently, PPME-FITC was added to all
tubes to a final dilution of 1:2,000. After 30 min on ice, samples
were directly analyzed by flow cytometry without an additional
washing step. The mean fluorescence intensity (MFI) of PPME-
FITC labeled cells was determined on a linear fluorescence scale,
and specific binding was determined after subtracting the MFI of
PPME-FITC in the presence of mAb DREG-200 (background
staining). In parallel, the average receptor number per cell was
determined using calibrated microbeads as described above. The
L-selectin lectin binding activity was expressed as specific fluores-
cence channel number per 100,000 L-selectin molecules.
 
Animal Preparation.
 
Mice were anesthetized by i.p. injection
of physiologic saline solution containing xylazine (1 mg/ml) and
ketamine (5 mg/ml). The left subiliac lymph nodes (LN) of male
and female 7–10-wk-old 129SV/C57BL/67 mice (21–23 g) were
prepared as described previously (5). In brief, the right femoral
artery of each anesthetized mouse was catheterized for retrograde
injection of BCECF-labeled cells. Subsequently, the left inguinal
fat pad containing the embedded LN was separated from the un-
derlying abdominal wall after a semicircular incision was made in
the abdominal skin. The animal was then placed on a custom-
made Plexiglas stage, with the skin flap containing the LN spread
over a sterile microscope slide, which was constantly kept moist
with saline. The fatty tissue covering the embedded LN was care-
fully removed, avoiding surgical damage to feeding or draining
blood vessels.
 
Intravital Microscopy.
 
Animals were transferred to an intravital
microscope (IV-500; Mikron Instruments). Microvessels were
Figure 1. Transfected selectins and their expression in L1-2 cells. (A) Schematic representation of
wild-type and chimeric selectins and distribution on L1-2 cells. The predicted number of amino acids
(counted from the NH2 terminus) of each transfected protein is indicated at the left and right of each bar.
The amino acid sequence at the splice site is shown with the number of the last amino acid of the ED.
The distribution of these molecules on transfected L1-2 cells has been described elsewhere (16), except
for L/CD31 (see text). The L-selectin ED and the TM/IC domains were drawn to scale based on their
predicted amino acid sequence. The ED of E-selectin is z60% longer than L-selectin, and was not drawn
to scale for clarity (indicated by diagonal lines). (B) Flow cytometry histograms showing typical cell sur-
face expression of wild-type and chimeric selectins. Wild-type L-selectin, L/CD31, and L/CD44 trans-
fectants were stained with anti–human L-selectin mAb DREG-200, as described in Materials and Meth-
ods. Wild-type E-selectin and E/L transfectants were stained with anti–human E-selectin mAb CL-3.
Staining of mock-transfected L1-2 cells (Vector) with either mAb yielded similar low background fluo-
rescence (shown is staining with DREG-200). (C) PPME-FITC binding to transfectants expressing wild-
type or chimeric L-selectin. PPME-FITC binding is expressed as specific MFI per 100,000 L-selectin
molecules; data are shown as mean 6 SD from four independent experiments. 
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observed through a 10
 
3
 
 (Zeiss Achroplan, NA 0.3 
 
`
 
) or 20
 
3
 
(Zeiss Achroplan, NA 0.5 
 
`
 
) water immersion objective. BCECF-
labeled cells were injected through the femoral artery catheter in
small boluses of 20–50 
 
m
 
l and visualized in the blood stream by
fluorescent epiillumination as described previously (5). The route
of cell injection into the inguinal artery which feeds the subiliac
LN directly via the superficial epigastric artery allowed us to de-
tect a sufficient number of cells that entered the LN during their
first pass through the downstream circulation while keeping the
overall number of injected cells low. Thus, when the injection of
a cell sample was stopped, the concentration of these cells in the
systemic circulation remained low, and very few recirculating cells
were found to enter the LN. This allowed us to inject a second
sample of transfectants with different ED distribution and to com-
pare the rolling behavior of both cell lines in the same venules. The
order in which transfectants were injected was randomized and did
not affect their rolling behavior (not shown). We did not attempt
to compare more than two cell samples per animal because the
number of recirculating cells from previous injections might have
become too high to allow a reliable analysis of a third cell sample,
and the total volume of injected fluids might have caused unac-
ceptable hemodynamic alterations.
At the end of each experiment, FITC-dextran (150 kD) was
injected to visualize the intravascular compartment for measure-
ment of vessel diameters and for determination of venular orders
(see below). All scenes were recorded on videotape using a low-
lag silicon-intensified target camera (VE1000SIT; Dage MTI), a
time base generator (For-A, Co., Ltd.), and a Hi-8 VCR (EVC-100;
Sony). At least three independent experiments were carried out
for comparison of each pair of transfected L1-2 cells.
 
Image Analysis.
 
Video analysis was carried out in real time or
at reduced speed as described (5, 30). Rolling (i.e., cells that in-
teracted visibly with the endothelium and traveled at a slower ve-
locity than the main blood stream) and noninteracting L1-2
transfectants were counted in each microvessel. The rolling frac-
tion was calculated for each transfectant as percentage of rolling
cells among the total number of cells passing a venule during a re-
corded time interval. Only microvessels with 
 
$
 
10 cells (total
number of cells) were considered for analysis. Included as rolling
cells were also cells that displayed jerky motion or skipping be-
havior. Velocity analysis was carried out by frame by frame analy-
sis of two representative vessels per experiment using a custom-
ized image analysis system for microcirculation research (31). For
the determination of labeled transfectant velocities, at least 10
consecutive rolling and 20 noninteracting cells were analyzed per
vessel and transfectant. 
 
V
 
roll
 
 was defined as the mean velocity
(
 
m
 
m/s) of rolling cells and 
 
V
 
fast
 
 as the mean velocity of noninter-
acting cells in each vessel. To correct for hemodynamic differ-
ences, 
 
V
 
roll
 
 was also expressed as percentage of 
 
V
 
fast
 
 (relative ve-
locity, 
 
V
 
rel
 
). For velocity histograms, the velocity of each
individual rolling cell was assigned to a velocity class, e.g., from
0 
 
m
 
m/s to 
 
,
 
50 
 
m
 
m/s; 50 
 
m
 
m/s to 
 
,
 
100 
 
m
 
m/s; and so on, and
the frequency of cells in each class was calculated as percentage of
all rolling cells analyzed. In addition, a cumulative velocity curve
was compiled by plotting the percentage of rolling cells traveling
at or below a given velocity as a function of 
 
V
 
roll
 
. Rolling frac-
tions and velocities were determined in identical venules for each
pair of transfectants, except for comparison of 
 
V
 
roll
 
 histograms of
L1-2 cells expressing wild-type L- and E-selectin, where data
from different experiments were pooled. In some cases, the dis-
placements of single fast and rolling cells between two video
frames (1/30 s) were measured over up to 25 video frames, and
plotted as a function of time.
As described previously, a venular tree in a typical murine PLN
consists of one or two collecting venules that receive blood from
smaller collecting venules and mid-size medullary venules, which
in turn drain small postcapillary venules in the sub- and paracortex
(3, 5, 29). Thus, these venules can be subdivided according to their
branching order, with terminal collecting venules corresponding to
order I, smaller collecting venules and midsize medullary venules
to order II or III, and postcapillary venules to order IV or V. Re-
cordings of FITC-dextran–injected preparations were used to de-
termine the venular order and to measure lumenal cross-sectional
diameter of blood vessels. From these measurements and the veloc-
ity of the fastest noninteracting cells, hemodynamic parameters
were calculated as described previously (5, 32).
 
Statistical Analysis.
 
Data are presented as mean 
 
6
 
 SEM unless
otherwise indicated. For comparison of rolling fractions of each
pair of transfected cells in identical venules, a paired Student’s 
 
t
 
test was employed. For comparison of 
 
V
 
roll
 
 of each pair of trans-
fectants the Mann-Whitney U test was employed. The Spearman
rank correlation test was used for analysis of linear regressions.
Statistical significance was set at 
 
P
 
 
 
,
 
 0.05.
 
Results
 
Distribution and Expression of Wild-Type and Chimeric L-
and E-Selectin on L1-2 Cells.
 
Fig. 1 A shows a schematic
representation of transfected selectins. The amino acid se-
quences at the fusion site between ED and TM/IC domain
of chimeric proteins are shown as well. Wild-type and chi-
meric selectins were previously found to have the follow-
ing preferential distribution on L1-2 cells, as determined by
quantitative analysis of immunogold distribution on labeled
cells using low voltage scanning electron microscopy (16):
L-selectin and E/L on the tips of microvilli (microvilli: 91 
 
6
 
11% and 83 
 
6
 
 6% of gold particles; cell body: 9 
 
6
 
 11% and
17 
 
6
 
 6%, respectively); E-selectin randomly distributed
over the entire cell surface (microvilli: 52 
 
6
 
 8%; cell body:
48 
 
6
 
 8%); and L/CD44 excluded from microvilli (mi-
crovilli: 5 
 
6
 
 5%; cell body: 95 
 
6
 
 5%) (16). We confirmed
these distribution patterns for the present study (not
shown) and also found that L/CD31 is randomly distrib-
uted similar to E-selectin (microvilli: 46 
 
6
 
 8%; cell body:
54 
 
6
 
 8%) (33 and data not shown).
To assure that ED distribution was the main factor for
tethering and rolling ability of the transfected cells (see be-
low), great care was taken to assure equivalent levels of ED
expression between L1-2 transfectants. Therefore, L1-2
transfectants were tested before and after each in vivo ex-
periment for comparable expression of EDs by FACS
 
®
 
analysis. Representative histograms are shown in Fig. 1 B.
Expression levels of EDs for each pair of transfectants are
listed in Table I.
To test whether the TM/IC domain had any influence
on the lectin binding activity, binding of lectin domains
to PPME-FITC of wild-type and chimeric L-selectin
transfectants was determined as described in Materials and
Methods. PPME-FITC binding of wild-type and chimeric
L-selectin was similar (Fig. 1 C; 
 
P
 
 
 
.
 
 0.05), indicating that
the lectin domain retains its functionality in cells expressing
chimeric L-selectin. 
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Behavior of Wild-Type and Chimeric L-Selectin Transfectants
in Subiliac PLN.
 
BCECF-labeled transfectants were in-
jected through the femoral artery and observed in subiliac
PLN microvessels. These vessels are classified in up to five
branching orders in a typical nodal venular tree as described
previously (3, 5). In agreement with previous studies of
L1-2 transfectants expressing wild-type L-selectin, we
found that their rolling fraction was highest in immediate
postcapillary venules (orders IV and V), gradually decreas-
ing in successively larger venules downstream (orders III to
I) (5). This decrease in rolling fractions was shown to cor-
relate with a decrease in PNAd density (29). Accordingly,
we found a similar spatial preference in rolling for chimeric
L-selectin transfectants (Fig. 2, A–C); irrespective of the ul-
trastructural distribution of L-selectin EDs, all cell lines
rolled consistently more frequently in high order venules
where L-selectin ligands were abundant, and displayed
much less rolling in medullary collecting venules with
sparse PNAd expression. Tethering and rolling was medi-
ated by the EDs of transfected selectins as mock-transfected
L1-2 cells were not able to tether and roll in this model (5).
In agreement with previous studies with L1-2 transfectants
in murine PLN, we did not observe transfectants that be-
came stuck (stationary for 
 
$
 
30 s) in any postcapillary
venule analyzed, probably because these cells express very
few 
 
b
 
2 integrins which are necessary for firm adhesion in
PLN HEV (3, 5).
 
L-Selectin Tethering Efficiency In Vivo Depends on ED Sur-
face Distribution.
 
To investigate the influence of receptor
distribution on the cell surface, we determined the rolling
fraction of pairs of transfectants that were injected at ran-
dom order in the same animal. The rolling fraction strongly
depended on the topography of L-selectin. L1-2 cells ex-
pressing wild-type L-selectin EDs that were located prefer-
entially on microvilli rolled more frequently than those that
 
were randomly distributed (L/CD31) or concentrated on
the cell body (L/CD44). L/CD31 receptors were more ef-
ficient than L/CD44 EDs (Fig. 2, A–C).
Although venules in all LN preparations supported sig-
nificant rolling of L1-2 transfectants, there was considerable
heterogeneity between individual experiments and be-
tween series of experiments that were performed during
different periods of time (compare rolling fractions of wild-
type L-selectin transfectants in Fig. 2 A and Fig. 2 B).
However, irrespective of the baseline adhesiveness of the
endothelial substrate, the ability of L1-2 transfectants to en-
gage in rolling invariably followed a topographic hierarchy:
microvillous 
 
.
 
 random 
 
.
 
 cell body presentation. To es-
tablish this relationship, we compared cell lines in a pair-
wise fashion, injecting one after another in the same animal,
and then calculated the relative rolling fraction for each pair
of transfectants in each venule. For this, the rolling fraction
of the cell line that displayed an overall lower frequency of
rolling was normalized to the rolling fraction of the other
cell line (Fig. 2 D). We found that wild-type L-selectin was
on average 1.87 
 
6
 
 0.19 (mean 
 
6
 
 SEM) times more effi-
cient at initiating interactions with PNAd than L/CD31
and 2.70 
 
6
 
 0.22 times more efficient than L/CD44. In
turn, 1.63 
 
6
 
 0.12 times more L/CD31 transfectants rolled
in LN venules compared with L/CD44 cells. This reveals
an incremental loss of tethering efficiency in vivo as EDs
are redistributed away from the tips of microvilli.
 
Microvillous Distribution of L-Selectin Is Most Important in
Venules of 
 
.
 
20 
 
m
 
m Diameter.
 
Lymphocyte–EC  interactions
in PLN take place mostly in immediate postcapillary
venules (diameter 10–20 
 
m
 
m) and venules created by
merging of these postcapillary venules (diameter 
 
.
 
20 
 
mm).
To test whether microvillous exposure of L-selectin is
more important in one or the other, we analyzed the role
of receptor distribution on L-selectin and L/CD44 trans-
Table I. Venular Microhemodynamics in PLN, Rolling Velocities, and ED Expression of L1-2 Transfectants
Number of 
venules/animals Diameter Vfast WSR Vroll (median) Vrel (median) ED expression
mm mm/s s21 mm/s % molecules/cell 
L-selectin 6/3 50.81 6 9.94 2,519 6 1,121 417 6 207 147 6 114 (99) 5.8 6 10.2 (4.5) 84,333 6 34,646
L/CD31 1,765 6 1,158 352 6 195 171 6 111 (148) 9.7 6 9.6 (8.4) 120,500 6 29,551
L-selectin 16/4 52.19 6 21.05 1,685 6 893 301 6 216 191 6 108 (171) 11.3 6 12.1 (10.1) 116,500 6 49,950
L/CD44 1,752 6 951 314 6 177 216 6 125 (209) 12.3 6 13.1 (11.9) 116,330 6 41,016
L/CD31 8/4 44.03 6 8.85 970 6 602 172 6 82 120 6 102 (87) 12.4 6 16.9 (9.0) 182,750 6 91,350
L/CD44 753 6 432 148 6 53 142 6 88 (121) 18.9 6 20.4 (16.1) 145,250 6 59,595
E-selectin 9/3 56.98 6 13.80 1,453 6 787 201 6 83 19 6 33 (8) 1.3 6 4.2 (0.6) 97,500 6 45,962
E/L 1,916 6 1,079 254 6 95 20 6 28 (11) 1.0 6 2.6 (0.6) 75,500 6 20,506
Mean velocities of noninteracting (Vfast) and rolling L1-2 transfectants (Vroll) were measured in at least two representative venules per animal. These data
combined with the venular diameter were used to calculate the wall shear rate and wall shear stress as described in Materials and Methods. To correct for
hemodynamic differences between subsequent observations of pairs of transfectants, Vroll was also expressed as percentage of Vfast (Vrel). The average receptor
number per cell was assessed for each transfectant on the day of an experiment as described in Materials and Methods. All data are presented as mean 6 SD.42 Role of L-Selectin Topography In Vivo
fectants in vessels of different diameters. The relative ad-
vantage of microvillous ED presentation in vessels of in-
creasing diameter was expressed as the ratio of the rolling
fractions of both transfectants in each individual venule
(Fig. 3). On average, 2.5 times more microvillous transfec-
tants than cell body transfectants rolled in the smallest
venules (10–20 mm diameter), whereas this ratio was in-
creased to 4.2 in vessels of twice that diameter (20–40 mm).
Indeed, there was a statistically significant linear correlation
between the relative advantage of microvillous transfectants
to initiate interactions in PLN venules and the diameter of
these venules (Spearman rank correlation test: P , 0.05).
L1-2 Cells Expressing Human E-Selectin Acquire the Ability
to Roll in PLN Venules. The results presented above are
strongly suggestive of a pivotal role of surface distribution for
L-selectin–dependent rolling. However, theoretically it re-
mained possible that the replacement of TM/IC domains in
the two mutants had conferred a distribution-independent
disadvantage in tethering efficiency relative to wild-type
L-selectin. For instance, a conformational change in the chi-
meric molecules could have altered the orientation of the
lectin domain that might have affected its ability to bind
surface-bound ligands (such as PNAd), but not freely diffus-
ible ligands (such as PPME-FITC). Therefore, we sought to
corroborate our findings using a molecularly distinct adhe-
sion pathway that could be tested in our in vivo system.
An earlier study has reported that E-selectin/IgG chi-
meric molecules bind to PNAd in HEV in frozen sections
of murine PLN and human tonsils (22), and E-selectin–
transfected cells were shown to bind to immobilized PNAd
(23). Thus, we tested whether L1-2 cells expressing human
E-selectin could interact with subiliac LN venules. Indeed,
cells expressing E-selectin EDs tethered and rolled in PLN
HEV similar to L-selectin transfectants, i.e., rolling frac-
tions were highest in order IV and V venules, and de-
creased in lower order venules (Fig. 4 A).
E-Selectin–mediated Rolling Is Slower than Rolling Via
L-Selectin, But Surface Distribution Is Equally Important for Teth-
ering. In almost all venules analyzed, E/L on microvilli
Figure 2. Rolling fractions of L1-2 transfectants expressing the L-selectin ED in PLN venules. L1-2
cells transfected with wild-type or chimeric L-selectin were fluorescently labeled with BCECF and
observed in PLN venules of different order. The percentage of rolling cells in the total cell flux (roll-
ing fraction) was determined in individual venules for each pair of transfectants, as described in Mate-
rials and Methods. Rolling fractions of each member of a pair that were determined in the same
venule are connected by straight lines. All transfectants showed highest rolling fractions in HEV of
orders IV and V, gradually decreasing when cells entered lower order venules. Separate experiments
were performed to compare rolling fractions between (A) wild-type L-selectin and L/CD31; (B)
wild-type L-selectin and L/CD44; and (C) L/CD31 and L/CD44. (D) Relative rolling fraction of
L1-2 transfectants in all venules after normalizing the transfectant with higher rolling fraction to 100%
in each venule; data are shown as mean 6 SEM of rolling fractions in 21–36 venules from three to six
independent experiments.
Figure 3. Microvillous ex-
pression of L-selectin confers en-
hanced tethering in all venules,
but is most critical in venules
with diameters above 20 mm.
Rolling fractions were deter-
mined as described in Materials
and Methods. The ratio of rolling
fractions of wild-type L-selectin
(microvillous) versus L/CD44
(cell body) transfectants was de-
termined for venules with differ-
ent diameters. Each point repre-
sents one venule. A ratio of one
(hatched horizontal line) indi-
cates equal rolling fractions, a ratio of two means that wild-type transfec-
tants rolled twice as frequently in a venule than L/CD44 cells, and so on.
A linear regression line was generated with the help of PC-based graphics
software (Sigma Plot). Note that rolling ratios in many venules with
diameters below 20 mm (indicated by vertical broken line) tend to be
lower than in larger vessels.43 Stein et al.
conferred higher rolling fractions than randomly distributed
E-selectin (Fig. 4 A). The relative rolling fraction of E/L
transfectants was 1.43 6 0.12 times higher than that of
wild-type E-selectin transfectants (Fig. 4 B).
Interestingly, cells transfected with E-selectin EDs rolled
at much slower velocities than wild-type L-selectin trans-
fectants (Fig. 5, A and B) despite comparable ED expres-
sion numbers and hemodynamic conditions (Table I). Ap-
proximately 95% of E-selectin transfectants rolled slower
than 50 mm/s, whereas only 9.6% of L-selectin transfec-
tants were found in this velocity class. The average (6 SEM)
Vroll in all venules combined was 19 mm/s 6 3.8 for wild-
type E-selectin transfectants (n 5 73 cells/9 venules/3 ex-
periments) and 181 6 6.9 mm/s (n 5 260/22/7) for wild-
type L-selectin transfectants.
Rolling Velocity Is Independent of Receptor Distribution.
To determine the role of ED distribution on Vroll, we car-
ried out a detailed analysis of single cell rolling velocities for
each pair of transfectants. Chimeric transfectants expressing
the L-selectin ectodomain showed similar average Vroll
when compared to their wild-type or other chimeric coun-
terparts (Table I). For further analysis of L1-2 cell rolling
behavior in PLN HEV, velocity histograms and cumulative
velocity curves were calculated as shown in Fig. 5. The ve-
locity histograms of pairs of cell lines tested in the same
preparation were comparable between all L-selectin trans-
fectants (Fig. 6, A, C, and E). Accordingly, the cumulative
velocity curves (Fig. 6, B, D, and F) were nearly superim-
posable. Likewise, E/L and wild-type E-selectin transfec-
tants were found to have similar velocity histograms and
cumulative velocity curves (Fig. 6, G and H). A statistical
comparison of the medians of the L/CD31-L/CD44 pair,
but not of any other pair, revealed a significant difference
(Mann-Whitney U test; P , 0.05). The low Vroll of L/CD31
cells in this group may have been due to their unusually
high expression of L-selectin EDs and relatively low shear
rates (Table I). No significant differences were found in
Vroll or Vrel with L/CD31 transfectants that expressed lower
ED levels during comparison with wild-type L-selectin
transfectants.
To detect subtle alterations in rolling behavior that
might remain unnoticed during measuring Vroll over a long
distance, we also analyzed the displacement of rolling and
noninteracting L-selectin and L/CD44 transfectants from
one video frame to the next (i.e., every 1/30 s) in identical
venules (Fig. 7, A and B). We were not able to detect qual-
itative differences in the rolling behavior of cells displaying
L-selectin on the microvilli or on the cell body. Both cell
types displayed a jerky rolling motion characterized by fre-
quent shifts in Vroll and brief hesitations that is also typical
for L-selectin–dependent rolling on PNAd in vitro (34).
Discussion
We have used murine pre-B cells transfected with wild-
type or chimeric L-selectin and E-selectin to assess the in-
fluence of adhesion receptor topography on rolling behav-
ior in vivo. We took advantage of a recently developed
model of intravital video microscopy to study the passage
Figure 4. Rolling fractions of
L1-2 cells expressing the E-selec-
tin ED in PLN venules. Rolling
fractions in PLN venules of trans-
fectants expressing E-selectin (ran-
dom distribution) and E/L chi-
mera (on microvilli) are presented
as in Fig. 2. (A) Rolling fractions
of E/L and wild-type E-selectin
transfectants in paired venules.
(B) Relative rolling fraction de-
termined by normalizing the
rolling fraction of E-selectin
transfectants to that of E/L trans-
fectants in each venule; data are
shown as mean 6 SEM of rolling
fractions in 18 venules from three
independent experiments.
Figure 5. E-selectin transfectants me-
diate slower rolling than L-selectin
transfectants. (A) A velocity histogram
was generated by measuring rolling ve-
locities of individual cells in PLN
venules as described in Materials and
Methods. Frequency distributions were
calculated after cells were assigned to ve-
locity classes from .0  mm/s to ,25
mm/s; 25 to ,50 mm/s; and so on. (B)
Cumulative velocity curves of E- and
L-selectin transfectants. The percentage
of rolling cells is expressed as a function
of Vroll (see Materials and Methods). n 5
number of cells/venules/experiments
analyzed.44 Role of L-Selectin Topography In Vivo
of fluorescently labeled cells through subiliac lymph nodes
(5). We chose the PLN model rather than other intravital
microscopy models because of the constitutive PNAd ex-
pression in lymph node vessels (6, 29), which supports re-
producible rolling interactions of L-selectin transfectants at
a much higher frequency than nonlymphoid tissues such as
the mesentery (5, 26, 35).
Our results demonstrate that (a) the ultrastructural sur-
face distribution of primary adhesion receptors has a strong
impact on the ability of transfectants to initiate adhesion to
EC; (b) the relative advantage of microvillous versus cell
body presentation is most accentuated in venules of 20–40
mm diameter; (c) E-selectin transfectants roll significantly
more slowly than L-selectin transfectants, presumably in-
teracting with the same substrate, PNAd, under compara-
ble hemodynamic conditions; and (d) once transfectants
begin to roll on EC, the rolling velocity is independent of
receptor distribution.
Using a flow assay in which transfectants were perfused
through ligand-coated glass capillaries, we have shown pre-
Figure 6. Rolling velocities of L- and E-selectin
transfectants are independent of ED distribution in
PLN venules. Velocity histograms were calculated
as in Fig. 5 except that individual cells of transfec-
tants were assigned to velocity classes with Vroll .
0 mm/s to ,50 mm/s; 50 to ,100 mm/s; and so
on (L-selectin transfectants) or .0  mm/s to ,5
mm/s; 5 mm/s to ,10 mm/s; and so on (E-selectin
transfectants). Cumulative velocity curves were cal-
culated as in Fig. 5 B. Velocity histogram and cu-
mulative velocity curve of (A and B) wild-type
L-selectin and L/CD31; (C and D) wild-type
L-selectin and C/CD44; (E and F) L/CD31 and
L/CD44 transfectants; and (G and H) wild-type
E-selectin and E/L. n 5 number of cells/venules/
experiments analyzed.45 Stein et al.
viously that microvillous expression of L-selectin allows
transfectants to initiate interactions with purified PNAd or
immobilized anti–L-selectin mAb more efficiently than cell
body expression of the same ED (16). However, tethering
in vivo occurs under much higher shear rates than possible
in flow chamber assays (18). Furthermore, ligand densities
are likely to differ under in vivo and in vitro conditions.
The negative charge associated with the glycocalyx of leu-
kocytes (19, 20) and EC (21) generating electrostatic repul-
sion might also be different in vivo compared to in vitro
assays. In addition, most flow chamber assays rely on grav-
ity to allow horizontally perfused leukocytes to collide with
the substrate-coated floor of the chamber, whereas the in-
fluence of gravitational forces is negligible for leukocyte
margination in vivo. Instead, blood-borne leukocytes are
forced into the proximity of ECs by anatomical constraints
(e.g., in capillaries) or by collision with other blood cells,
particularly erythrocytes (17). These physiologic factors are
difficult to reproduce in vitro, although one study has re-
ported increased leukocyte–EC interactions after infusing
red blood cells into a flow chamber (36). Therefore, it has
been unclear whether and to what extent adhesion receptor
presentation on microvilli is necessary for contact forma-
tion between free-flowing leukocytes and EC under physi-
ologic conditions. Here we show that microvillous presen-
tation of L-selectin conferred a much higher tethering
capability compared with cell body presentation (L/CD44)
and with randomly distributed adhesion receptors (L/CD31)
in almost all venules analyzed. Furthermore, we also ob-
served an advantage of randomly distributed L/CD31 over
microvillous-excluded L/CD44.
Interestingly, there was no significant correlation be-
tween the wall shear rate and the rolling ratio of L-selectin
versus L/CD44 transfectants (not shown). This is in con-
trast to in vitro findings, where the importance of microvil-
lous L-selectin was much more pronounced at higher shear
rates (16). This apparent difference between in vivo and in
vitro experiments underscores the importance of collisions
between leukocytes and erythrocytes in venules, which
have been shown to be the principal mechanism of leuko-
cyte margination at high shear (17, 36). As shear rates in-
crease, the duration of contacts with the endothelium will
be shortened, leading to a reduced likelihood of tether for-
mation, especially for nonmicrovillous receptors. However,
at the same time collisions with RBCs are likely to become
more frequent and more forceful, thus allowing more flex-
ing of microvilli and enhanced exposure of cell body re-
ceptors. These two opposing mechanisms may cancel each
other out, resulting in an overall constant role for microvil-
lous receptor topography over a wide range of shear rates.
However, we found that the relative advantage of mi-
crovillous versus cell body presentation of L-selectin EDs
was most accentuated in venules with diameters of .20
mm, whereas postcapillary venules with diameters ,20
mm supported tethering of cell body transfectants that was
relatively more frequent, yet still lower than observed for
wild-type transfectants. This attenuated effect in very small
HEV might be explained by a forced margination phenom-
enon that occurs preferentially in immediate postcapillary
venules (17). When a leukocyte (or L1-2 cell) encounters
the capillary bed, its cellular diameter frequently exceeds
the diameter of the capillary ostium. Therefore, the cell is
forced to deform itself (37) before it can be squeezed
through the narrow capillary. During the ensuing brief de-
lay, blood plasma flows around the slow moving cell result-
ing in a cell-free plasma gap downstream of the leukocyte
while erythrocytes pile up behind its trailing end (17). After
entering wider postcapillary venules, the stiff and large leu-
kocyte still experiences considerable drag, even in the ab-
sence of adhesive interactions. The smaller and highly de-
formable erythrocytes that have accumulated behind the
leukocyte in the capillary now have sufficient space to pass
the leukocyte and push it against the venular endothelium.
This phenomenon might cause some flexing of microvilli
and, thus, might enhance the accessibility of L-selectin EDs
located on the cell body. However, this effect may fade as
leukocytes pass into postcapillary vessels of larger diameter
where erythrocyte-induced margination may be less force-
ful (Fig. 8). In addition, the endothelial wall of HEV bulges
out into the luminal space of postcapillary venules (orders
IV and V), thus increasing the probability of leukocyte–EC
collisions (5). On the other hand, the endothelial lining of
larger venules (orders III and lower) is more flattened (38),
which might enhance the need for exposing L-selectin to
Figure 7. Similar rolling behavior of
cells displaying L-selectin on the mi-
crovilli or on the cell body. The dis-
tance traveled between two video
frames (1/30 s) was determined for five
randomly chosen rolling cells (filled cir-
cles) and three fast cells (open circles) in
the same venule (320 lens). The y-axis
indicates the length (in mm) traveled,
with zero as the upstream entry point
into the venule. Symbols connected by
lines indicate the relative position of a
cell at each of up to 25 consecutive
video frames. The time at which the
cells enter the field of view is arbitrary.
(A) L-selectin transfectants; (B) L/CD44
transfectants.46 Role of L-Selectin Topography In Vivo
initiate contact with endothelial counterreceptors. Taken
together, these factors might explain the increasing tether-
ing advantage of microvillous L-selectin with increasing di-
ameter. Thus, our findings highlight the different condi-
tions encountered during in vivo and in vitro assays;
whereas the differential effect of microvillous versus cell
body presentation was shown in vitro to be a function of
shear (16), we find that this effect is a function of the vessel
diameter in vivo.
Our data also show that E-selectin transfectants were
able to tether and roll in PLN venules. E-selectin/Ig chi-
mera has been reported previously to recognize HEV in
immunohistochemical stainings (22). Furthermore, E-selec-
tin has been shown to bind to PNAd coated on glass slides
(23). Although E-selectin is normally only expressed on EC
(39), the transfectants used in this study are a useful model
to investigate the impact of differential receptor topography
on tethering efficiency using an adhesion pathway that does
not involve L-selectin. Analogous to wild-type L-selectin
and L/CD31, we found that microvillous E/L conferred
higher tethering efficiency compared to randomly distrib-
uted E-selectin. Thus, the ability of adhesion receptors to
initiate interactions with their ligands under physiologic
conditions is dependent on their surface distribution; mi-
crovillous, i.e., most distally positioned EDs, are more effi-
cient than randomly distributed ones, which in turn are
more efficient than cell body expressed receptors.
It might be argued that the TM/IC domains influenced
the ability of EDs to bind to their ligands in some other
way, e.g., by altering the structure or function of the ED.
However, all transfected cell lines displaying L-selectin EDs
were shown to bind PPME-FITC similarly. This shows
that the lectin domain of L-selectin involved in binding to
endothelial counterreceptors remained unaffected by the
(chimeric) nature of its TM/IC domain. Due to the lack of
an appropriate reagent, we were not able to test the lectin
binding activity of wild-type and chimeric E-selectin.
However, E/L and wild-type E-selectin transfectants rolled
at equivalent velocities suggesting that the lectin activity of
chimeric E-selectin remained unaffected by its TM/IC do-
main. Moreover, domain swapping in E/L cells resulted in
a gain of function, i.e., enhanced tethering efficiency of
chimeric over wild-type transfectants. This indicates that
the effects of replacing TM/IC domains on the tethering
ability of selectin EDs are most likely due to changes in to-
pographic distribution and not altered ED conformation.
Our experiments do not exclude the possibility that the
cytoskeletal association was different between wild-type and
chimeric molecules. Indeed, it is likely that differential inter-
actions of TM/IC domains with domain-specific cytoskele-
tal components were responsible for the observed topo-
graphic specificities. However, it appears probable that each
of the molecules expressed in L1-2 cells was anchored suffi-
ciently. It has been reported that transfectants expressing
truncated L-selectin that lacked most of the intracellular do-
main and no longer appeared to be linked to the cytoskele-
ton failed to bind endothelial counterreceptors in vitro and
in vivo (40). Moreover, disruption of the actin-based cyto-
skeleton with cytochalasin B or D was found to greatly re-
duce the tethering efficiency of cell lines transfected with
L-selectin and of human neutrophils (16, 40, 41). The find-
ing that the transfectants used here retained a certain capacity
to initiate rolling and the observation that Vroll was equiva-
lent between cells with the same ED indicates that the cell
lines used in this study presented their transfected adhesion
molecules sufficiently anchored in the cell membrane. Thus,
the cell surface distribution pattern conferred by TM/IC do-
mains is likely to be the main factor in determining the abil-
ity of transfected cells to tether to the endothelium.
It cannot be excluded that intracellular signaling via
TM/IC domains may be altered in chimeric proteins.
However, contact initiation between free-flowing lympho-
cytes and endothelium is a nearly immediate process that is
unlikely to require prior signaling. However, it is conceiv-
able that downstream signaling events initiated by primary
adhesion receptors may be triggered by their engagement
in rolling interactions. In circulating lymphocytes which
rely on L-selectin to initiate adhesive contact when they home
to PLN, such early events could contribute at later stages, such
as during firm arrest and transmigration (3, 42, 43).
Most other adhesion receptors capable of initiating con-
tact with EC under flow are also targeted to the tips of mi-
crovilli, such as PSGL-1 (13) and the a4 integrins (14, 15).
Figure 8. A differential role for microvillous receptor presentation in
PLN microvessels of different sizes. (1) RBCs pile up behind slower mov-
ing leukocytes in narrow capillaries (C, diameter 5–10 mm). As capillary
ECs are not adhesive, there is no apparent binding despite the close prox-
imity between cell membranes. (2) When entering the smallest postcapil-
lary venules (PCV, diameter 10–20 mm), RBCs pass through the gap be-
tween the leukocyte and the venular wall and push the slow moving
leukocyte against endothelial counterreceptors. This may promote contact
initiation between leukocytes and EC (forced margination [17]). In this
process, microvilli may be flexed, leading to exposure of some nonmi-
crovillous receptors. (3) In larger postcapillary and collecting venules (CV,
diameter .20 mm), leukocytes experience little drag and move at a similar
velocity as erythrocytes. Thus, collisions with RBCs might be less forceful,
thereby enhancing the need of microvillous presentation of adhesion re-
ceptors to contact EC counterreceptors. (4) Once rolling has been estab-
lished, the cell surface distribution of adhesion receptors mediating rolling
does not seem to be important as leukocytes are pushed against the venular
wall and become flattened to allow receptors located on any part of the cell
surface to interact with endothelial counterreceptors.47 Stein et al.
In addition, the cutaneous lymphocyte antigen, an sLex-
like carbohydrate determinant on myeloid and lymphoid
cells which mediates binding to E-selectin, has been re-
ported to be associated with PSGL-1 (44). Therefore, it is
likely that at least some E-selectin ligands are also preferen-
tially expressed on the tips of microvilli. These findings,
combined with our data, support the hypothesis that white
blood cells optimize their recruitment by exposing the
molecules that initiate adhesion on the most distal parts of
their surface. On the other hand, secondary adhesion re-
ceptors mediating firm adhesion after rolling, such as b2 in-
tegrins, are found on the cell body (10).
Other adhesion molecules, such as E-selectin ligand-1 or
CD44, are targeted to the side of microvilli (45) or to the
cell body, respectively (16). Both can mediate some degree
of adhesion on their respective ligands in vitro (46, 47).
However, their role in initiating contact with EC in vivo is
unclear. Conceivably, these receptors may participate pri-
marily in the strengthening of rolling once contact has been
initiated by other adhesion molecules on the tips of mi-
crovilli. On the other hand, our data show that randomly
or microvilli-excluded EDs are also able to initiate contact
under physiologic conditions, albeit much less efficiently
than EDs on the tips of microvilli.
E-selectin transfectants rolled considerably more slowly
(z10-fold) than L-selectin transfectants. All selectins bind
to composite ligands containing sLex-like carbohydrate
structures (48). Both L- and E-selectin can recognize
PNAd (23), but their binding sites may not be identical
(22). For example, L-selectin binding to human and mu-
rine HEV using immunohistochemical methods can be
blocked by fucoidan, but remains unaffected by soluble
sLex, whereas the opposite is the case for E-selectin (22).
Furthermore, L-selectin requires sulfated ligands under
physiologic conditions (7), whereas E-selectin may not
(47). Thus, it cannot be excluded that the ligand density
in HEV was much higher for E-selectin in HEV than for
L-selectin, which may have contributed to the differences
in Vroll. However, L-selectin ligands are abundantly ex-
pressed in PLN, in particular in high order HEV (29).
Moreover, there was no detectable difference in Vroll be-
tween high and low order venules (not shown). Thus, it
seems unlikely that the density of L-selectin ligands on
HEV was a limiting factor that influenced the rolling ve-
locity of cells expressing the L-selectin EDs. In addition,
neutrophils have been found to roll 8–11.5-fold faster on
the L-selectin ligand CD34 than on E-selectin in flow
chamber assays when both substrates were used at compa-
rable site densities (49). We found a similar ratio using cells
expressing similar numbers of L- or E-selectin ED under
comparable physiologic conditions. Therefore, it is likely
that intrinsic differences in the bond lifetime, with E-selec-
tin having a much longer bond lifetime compared to L-selec-
tin (49), are responsible for the slower rolling of E-selectin
transfectants.
It has been suggested in several theoretical models of leu-
kocyte rolling that the spacing between adhesion receptors
on the tips of microvilli engaged in interactions with EC
counterreceptors plays a role in determining the velocity of
rolling leukocytes (50, 51). To address this question, we
assessed the influence of cell surface distribution of L- and
E-selectin on Vroll and Vrel. Hemodynamic parameters were
comparable for each pair of transfectants tested, although
the average Vfast was somewhat lower for the comparison of
L/CD31 and L/CD44 transfectants than for the other pairs,
reflecting random variability between preparations.
Our analysis revealed that the rolling velocity is indepen-
dent of receptor topography for each pair of transfectants
investigated. It is conceivable that microvilli constitute
flexible structures that may quickly adapt to forces exerted
by the flowing blood (Fig. 8). Indeed, previous in vivo
studies suggest that rolling leukocytes become flattened as
they are pushed against ECs by the flowing blood (18).
Thus, our in vivo findings do not agree with theoretical
models of leukocyte rolling where microvilli are assumed
to be rigid structures whose spacing determines the distance
between successive adhesion events in flow direction medi-
ated by microvillous receptors, thereby determining the
rolling velocity at a given flow rate (50, 51). Several factors
might explain these differences. First, the torque acting on
a rolling leukocyte under shear can be divided in two per-
pendicular force vectors, one acting in the direction of
flow, the other normal to the endothelium (34). The
higher the shear stress, the more leukocytes are pushed
against EC by the normal force, thereby they are forced to
flatten (18). Second, RBCs colliding with rolling leuko-
cytes might push leukocytes further against the endothe-
lium. Third, the trailing end of a rolling cell experiences
most of the tensile force that pulls transmembrane recep-
tors. This may lead to stretching of the downstream plasma
membrane in the area of contact with the vascular wall and
cause flattening or retraction of microvilli. However, it
must be noted that cell flattening does not necessarily mean
that microvilli are not present at the contact surface be-
tween leukocytes and ECs. Alternatively, they might be
pushed aside, with the adhesion receptors on the trailing
edge conferring the necessary contact to the endothelial
counterreceptors. In any event, the structural changes in
the contact zone between the rolling cell and the venular
endothelium appear to allow receptors on all microdomains
(i.e., microvillous and nonmicrovillous) to contribute to
the overall strength of the interaction. This would explain
the congruence of Vroll that was observed to occur between
cells that express adhesion molecules on different surface
domains while in suspension, and might enable adhesion
receptors on other parts of the cell, such as b2 integrins on
the cell body, to interact with EC counterreceptors.
In conclusion, we have demonstrated that the surface
distribution of leukocyte adhesion receptors plays a critical
role in initiating contact between circulating leukocytes
and endothelial ligands under physiologic conditions. We
confirm data from previous in vitro assays showing that
presentation of L-selectin on the surface of leukocytes has a
dramatic impact on tethering efficiency and we expand
the data to the in vivo situation. Furthermore, our data
suggest a differential advantage of microvillous presentation48 Role of L-Selectin Topography In Vivo
of L-selectin in vivo that is inversely correlated with the
venular diameter, but does not seem to be correlated with
the shear forces. Our findings also reveal that topography is
important for tethering but it does not influence the
strength of established rolling interactions. These observa-
tions support the hypothesis that exposed presentation of
primary adhesion receptors increases interactions between
leukocytes and endothelium in vivo and constitute an addi-
tional refinement of the multistep adhesion cascade.
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